Intervention

Placebo DPI

ClinicalTrials.gov intervention label

Clinical trials11

Recruiting1

Common conditions7

Lead sponsors shown5

Clinical trials

11 shown

Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting BronchodilatorsNCT07133880 · 2023-12-05

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant DepressionNCT03965858 · 2019-02-25

An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With AsthmaNCT03478657 · 2018-06-18

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)NCT03590379 · 2018-06-15

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled AsthmaNCT02567708 · 2015-10-01

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT02275052 · 2015-01-23

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02257372 · 2014-09-30

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety EvaluationNCT02210806 · 2014-07-01

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety EvaluationNCT01581177 · 2012-04-01

QTc Study GSK573719+GW642444NCT01521377 · 2011-12-19

Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006NCT01189396 · 2010-07-01

Common conditions

Asthma4 Pulmonary Disease, Chronic Obstructive4 Bronchospasm1 Chronic Obstructive Pulmonary Disease1 Chronic Obstructive Pulmonary Disease (COPD)1 COPD (Chronic Obstructive Pulmonary Disease)1 Major Depressive Disorder1

Leading sponsors

GlaxoSmithKline5 Amphastar Pharmaceuticals, Inc.3 Celon Pharma SA1 Chiesi Farmaceutici S.p.A.1 University of Tennessee Graduate School of Medicine1

Trial status mix

COMPLETED10

RECRUITING1

Phase mix

PHASE26

PHASE44

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.